Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Commercial Officer

President and CEO

EVP, Gen. Counsel, Corp. Sec.

Senior VP, Finance & CAO

VP, Finance & Corp Controller

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. The company is headquartered in New York, New York.

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherap...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-01-22	Premium	acquired	Premium	Premium	Premium	-
2024-01-22	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-01-22	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-01-22	Premium	acquired	Premium	Premium	Premium	CFO
2024-01-22	Premium	acquired	Premium	Premium	Premium	-
2024-01-22	Premium	acquired	Premium	Premium	Premium	-
2024-01-22	Premium	acquired	Premium	Premium	Premium	-
2024-01-22	Premium	acquired	Premium	Premium	Premium	-
2024-01-22	Premium	acquired	Premium	Premium	Premium	EVP, Gen. Counsel, Corp. Sec.
2023-12-06	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-12-06	Premium	sold	Premium	Premium	Premium	EVP, Gen. Counsel, Corp. Sec.
2023-12-06	Premium	sold	Premium	Premium	Premium	CFO
2023-12-06	Premium	sold	Premium	Premium	Premium	President and CEO
2023-02-02	Premium	acquired	Premium	Premium	Premium	-
2023-02-02	Premium	acquired	Premium	Premium	Premium	-
2023-02-02	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2023-02-02	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-02-02	Premium	acquired	Premium	Premium	Premium	CFO
2023-02-02	Premium	acquired	Premium	Premium	Premium	-
2023-02-02	Premium	acquired	Premium	Premium	Premium	-
2023-02-02	Premium	acquired	Premium	Premium	Premium	-
2023-02-02	Premium	acquired	Premium	Premium	Premium	EVP, Gen. Counsel, Corp. Sec.
2022-12-05	Premium	sold	Premium	Premium	Premium	President and CEO
2022-12-05	Premium	sold	Premium	Premium	Premium	Senior VP, Finance & CAO
2022-12-05	Premium	sold	Premium	Premium	Premium	EVP, Gen. Counsel, Corp. Sec.

SLS - SELLAS Life Sciences Group Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for SLS